Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not yet recruiting

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

NCT06651203

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

NCT06647329

Conditions: CAR-T Cell Therapy, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
Locations: the First Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Not yet recruiting

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

NCT06646211

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence

NCT06644339

Conditions: Arterial Hypertension, Cardiovascular Diseases, Diabetes Mellitus, +15 more
Locations: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), University Clinical Hospital No.1 Moscow, Russia

View Trial Details

Not yet recruiting

Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)

NCT06549335

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Not yet recruiting

Nintedanib Treatment in Unicentric Castleman Disease

NCT06643091

Conditions: Castleman Disease, Hemic and Lymphatic Diseases, Immune System Diseases, +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

NCT06641024

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Rui Jin hospital, Shanghai Jiao Tong university school of medicine Shanghai, China

View Trial Details

Not yet recruiting

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

NCT06594211

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Distraction As Multimodal Pain Management

NCT06591195

Conditions: Acute Pain, Agnosia, Burns, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

NCT06594432

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hematological Department, People's Hospital of Jiangsu Province Nanjing, Jiangsu, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions